100% pass customs Raw steroids Powder Raloxifene Hcl Pharmaceutical Grade for cancer therapy

Cancer Treatment Steroids 99.9% powder Raloxifene hcl for breast carcinoma

Raloxifene Hydrochloride
Alias: Raloxifene HCl; KEOXIFENE; AKOS 92138
CAS: 82640-04-8
Purity: 99%
MF: C28H28ClNO4S
MW: 510.04
Appearance: Light yellow powder
Related Substances: Pharmaceutical Grade
Storage: Shading, confined preservation
Lead time: within 8 hours upon receipt of payment
Usage: It is used in the prevention of osteoporosis in postmenopausal women.

Product Description:

Evista (Raloxifene Hydrochloride) is an estrogen agonist/antagonist, referred to as a selective estrogen receptor modulator (SERM) and belongs to the benzothiophene class of compounds. The biological actions of Raloxifene are largely mediated through binding to estrogen receptors. This binding results in activation of estrogenic pathways in some tissues (Agonism) and and the blockade of estrogenic pathways in other tissues (Antagonism).

For bodybuilding purposes Adipex-P is often administered during the pre-contest phase of training. When taken in conjunction with all the pre-contest principles that would be employed anyway, i. e. Cardio and weight training exercise, behavioral modification, caloric restriction, increased protein consumption, etc., Adipex-P can be a great addition to the carbohydrate craving/depleted diet regimen.

The usual adult dose is one tablet (37.5 mg) daily, administered before breakfast or 1-2 hours after breakfast. Bodybuilder dosage recommendations are consistent with those of patients, and should be individualized to obtain an adequate response with the lowest effective dose. For some patients or bodybuilders half a tablet (18.75 mg) daily may be adequate, while others might take half a dose twice daily. Raloxifene is a selective estrogen receptor modulator (SERM); acts as an anti-estrogen in both breast and uterine tissue while being estrogenic in bone. May have efficacy against estrogen-sensitive cancers.